Physician profile
Jason E Levine
NPI 1790195287
$8,465.58
in general payments reported to CMS, 2019-2025
14 companies · $268 in 2025
The $268 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,578 · 2020: $428 · 2021: $1,231 · 2022: $1,439 · 2023: $367 · 2024: $155 · 2025: $268.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $789.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $789.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Southern Edge Orthopaedics, INC. | $6,890.45 | 2019-2022 | |
| Arthrex, INC. | $516.00 | 2019 | |
| Smith+Nephew, INC. | $362.59 | 2021-2025 | Collagenase Santyl, Regranex, Grafix Pl |
| Organogenesis INC. | $159.44 | 2025 | Cygnus Matrix, Puraply Wound Matrix |
| Stryker Corporation | $125.63 | 2023 | Prophecy |
| Horizon Therapeutics Plc | $123.52 | 2022 | |
| Convatec INC. | $57.86 | 2024-2025 | |
| Abbvie INC. | $56.73 | 2023 | |
| Ets Wound Care LLC | $53.89 | 2024 | Mirragen Advanced Wound Matrix |
| Treace Medical Concepts, INC. | $45.51 | 2023 | |
| Paratek Pharmaceuticals, INC. | $23.08 | 2022 | |
| Integra Lifesciences Corporation | $19.61 | 2025 | Tcc-Ez |
| Kowa Pharmaceuticals America, INC. | $16.19 | 2023 | Seglentis |
| Pacira Pharmaceuticals Incorporated | $15.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Levine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.